GlassScriptPhysician profile
Julia P Gutierrez
NPI 1487188165
$2,213.06
in general payments reported to CMS, 2019-2025
23 companies · $607 in 2025
The $607 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $10.04 · 2022: $361 · 2023: $645 · 2024: $590 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,841.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $333.32 | 2023-2025 | |
| Dysis Medical, INC. | $243.58 | 2022 | |
| Novo Nordisk INC | $220.04 | 2023-2025 | Wegovy |
| Shield Therapeutics INC | $161.89 | 2023-2025 | Accrufer |
| Sumitomo Pharma America, INC. | $134.95 | 2024-2025 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $133.36 | 2023-2025 | Myosure Tissue Removal Device, Aptima, Novasure |
| Evofem Biosciences, INC. | $132.90 | 2023-2025 | Phexxi, Solosec, Phexx |
| Biogen, INC. | $126.77 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $125.57 | 2023-2025 | Slynd |
| Organon LLC | $105.11 | 2021-2025 | Nexplanon |
| Lilly USA, LLC | $93.85 | 2022-2025 | Zepbound |
| Astellas Pharma US INC | $91.43 | 2024-2025 | Veozah |
| Axonics, INC. | $79.50 | 2023 | Axonics |
| Boston Scientific Corporation | $36.47 | 2025 | Axonics |
| Abbvie INC. | $34.26 | 2023-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $32.47 | 2022-2023 | Balcoltra |
| Myovant Sciences INC. | $26.28 | 2022 | |
| Becton, Dickinson and Company | $20.98 | 2022 | |
| Merck Sharp & Dohme LLC | $18.79 | 2024 | Gardasil, Gardasil 9 |
| Coopersurgical, INC. | $18.54 | 2024 | Paragard T 380a |
| Therapeuticsmd, INC. | $18.15 | 2022 | |
| Agile Therapeutics, INC. | $12.97 | 2022 | |
| Aspira Women'S Health INC | $11.88 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Gutierrez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.